Support Alert

Epanutin (phenytoin) 30mg/5ml oral suspension supply disruption

The Department of Health and Social Care (DHSC) has advised that Pfizer expect that Epanutin (phenytoin) 30mg/5ml oral suspension will be out of stock from w/c 10th June for 6-8 weeks. 

The Canadian brand of Epanutin® ‘Dilantin-30’ is equivalent to Epanutin 30mg/5ml oral suspension and supplies are available on an ‘unlicensed’ basis.

Different formulations of phenytoin (other than Dilantin 30mg/5ml oral suspension) are not interchangeable and if patients are switched to anything other than ‘Dilantin (phenytoin) 30mg/5ml oral suspension’ careful management of switching and monitoring is required. 

Further details of the supply disruption and actions to be taken can be found here.

Further information:
Letter from Pfizer 
Epanutin PIL and SPC
Dilantin PIL and monograph 


Renew for 2022

Your dedication to patient care has made us proud during 2021.

That's why you can count on us to represent your interests and support your efforts every step of the way in 2022.